Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Arcutis Biotherapeutics Inc shares valued at $25,177 were purchased by Heron Patrick J on Jun 04 ’25. At $13.32 per share, Heron Patrick J acquired 1,890 shares. The insider’s holdings grew to 24,424 shares worth approximately $0.33 million following the completion of this transaction.
Also, Heron Patrick J purchased 378 shares, netting a total of over 5,069 in proceeds. Following the buying of shares at $13.41 each, the insider now holds 24,802 shares.
Before that, Matsuda Masaru had sold 1,800 shares from its account. In a trade valued at $24,807, the insider traded Arcutis Biotherapeutics Inc shares for $13.78 each. Upon closing the transaction, the insider’s holdings decreased to 1,800 shares, worth approximately $2.74 million.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Arcutis Biotherapeutics Inc [ARQT] has been a Buy and the price target has been revised to $19. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 03, 2024, Mizuho has increased its “Neutral” rating to a “Buy” for ARQT. Earlier on October 26, 2023, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for ARQT stock which previously was a “a Buy”.
Analyzing ARQT Stock Performance
During the last five days, there has been a drop of approximately -0.07%. Over the course of the year, Arcutis Biotherapeutics Inc shares have dropped approximately -3.09%. Shares of the company reached a 52-week high of $17.75 on 03/25/25 and a 52-week low of $11.13 on 02/11/25.
Support And Resistance Levels for Arcutis Biotherapeutics Inc (ARQT)
According to the 24-hour chart, there is a support level at 13.31, which, if violated, would cause prices to drop to 13.13. In the upper region, resistance lies at 13.74. The next price resistance is at 13.99. RSI (Relative Strength Index) is 45.85 on the 14-day chart, showing neutral technical sentiment.
